Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

Despite weathering significant criticism from lawmakers and patient groups over the steep cost of its rare disease med ...

Healey plans to host a ceremony at 11 a.m. Wednesday with legislative leaders to sign both the prescription drug bill and a ...

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Oncology drugs tend to “percolate to the top” of shortage lists that prioritize drugs of concern, said expert.

The national group representing generic drug and biosimilar manufacturers is looking to replicate its success challenging ...

Randy Yost, 72, who owns Randy’s Gateway Drug in Richlands, pleaded guilty in May to health care fraud, conspiracy to commit ...

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.

Beyond the influence of new therapies on drug pricing trends, Cowen’s report also accounted for the effects of legislation ...

New research from University of Iowa dispels the belief that pharmaceutical mergers lead to higher drug prices, showing a decrease in prices for generic drugs.